Clik here to view.
Cell Signaling Technology凭借 GMP能力扩大产品阵容
马萨诸塞州丹弗斯 (美国商业资讯)–高品质抗体的全球性提供商Cell Signaling Technology, Inc. (CST)今天宣布，该公司同类产品中最佳的重组兔单克隆抗体已能按GMP （良好生产规范）要求生产，该抗体是采用该公司专利XMT® 和NG-XMTTM发现技术开发的。 CST首席科学官Roberto...
View ArticleClik here to view.
Jubilant DraxImage在哥伦比亚上市HICON®
蒙特利尔 — (美国商业资讯) — Jubilant DraxImage Inc. (“DraxImage”)欣然宣布，HICON® 碘化钠I-131溶液USP的首次商业发货今天已到达哥伦比亚波哥大。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Clik here to view.
セル・シグナリング・テクノロジーがGMP認証によりポートフォリオ拡大
米マサチューセッツ州ダンバース （ビジネスワイヤ）– 高品質の抗体を提供する世界的企業のセル・シグナリング・テクノロジー（CST）は本日、当社専有のXMT®/NG-XMTTM創薬技術を活用して開発したクラス最高の組み換えウサギモノクローナル抗体が、GMP（適正製造基準）の要件に従って製造できるようになったと発表しました。 CSTの最高科学責任者（CSO）であるRoberto...
View ArticleClik here to view.
Jubilant DraxImageがコロンビアでHICON®を発売
モントリオール — （ビジネスワイヤ） — Jubilant DraxImage Inc.（以下「DraxImage」）は、コロンビアのボゴタに向け本日、HICON®ヨウ化ナトリウム (131I)溶液（米国薬局方）を初めて商業出荷したことを発表します。 このSmart News...
View ArticleClik here to view.
新たながん研究の資金調達活動をフェルド・エンターテイメントとプライマリー小児病院が発表
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米フロリダ州エレントン （ビジネスワイヤ） —...
View ArticleClik here to view.
Clik here to view.
Feld Entertainment 和 Primary Children’s Hospital宣布新的癌症研究筹款计划
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 佛罗里达州埃伦顿 (美国商业资讯)–Feld Entertainment, Inc.（ Ringling Bros. and Barnum & Bailey® 和Ringling Bros. Center for Elephant...
View ArticleClik here to view.
Dr. Reddy’s to Release Q2FY16 Results on Oct 29, 2015 // Earnings Call Slated...
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) will announce results for the Second Quarter and Half year ended September 30, 2015 on Thursday, October 29, 2015 after the Board Meeting. The...
View ArticleClik here to view.
Cold Genesys Announces FDA Acceptance of a Phase I/II Clinical Trial Using...
SANTA ANA, Calif. Cold Genesys, Inc., a late-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration (FDA) accepted a Phase I/II Clinical Trial (NAOMI) using CG0070...
View ArticleClik here to view.
武田即将在美国血液学会年会上呈报Ixazomib治疗复发/难治多发性骨髓瘤的3期研究数据
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE: 4502)今天宣布，该公司将在美国血液学会(ASH)第57届年会上呈报ixazomib 3期临床试验TOURMALINE-MM1 的数据，该年会将于2015年12月5至8日在佛罗里达州奥兰多召开。总计19篇代表武田血液学-肿瘤学产品阵容广度和深度的公司赞助摘要被今年的会议接受进行呈报。...
View ArticleClik here to view.
C2 Therapeutics发布的新数据证实Coldplay CryoBalloon®局灶性消融系统治疗食管疾病的有效性和安全性
加州红木城 (美国商业资讯)– C2 Therapeutics是一家私有企业，创立宗旨是改进食管癌前驱症状（Barrett’s食管或BE）的治疗。该公司今天宣布，两项强调该公司Coldplay CryoBalloon® 局灶性消融系统有效性和安全性的研究于10月24-28日在巴塞罗那召开的欧洲联合胃肠病周期间呈报。 第一项研究是口头呈报，该项进行中的多中心前瞻性试验评估Coldplay...
View ArticleClik here to view.
Konica Minolta to Start In Vitro Diagnostics Business in European and...
TOKYO Konica Minolta, Inc. (Konica Minolta) (TOKYO:4902) (ISIN:JP3300600008) today announced that it has developed the SPFS Immunoassay System,*1 an immunoassay system capable of highly sensitive...
View ArticleClik here to view.
Starpharma’s Targeted DEP™ Outperforms Leading Treatments in Ovarian Cancer...
MELBOURNE, Australia Starpharma (ASX: SPL) (OTCQX: SPHRY) today announced that treatment with its novel antibody-targeted DEP® conjugate resulted in complete tumour regression and 100% survival in...
View ArticleClik here to view.
Spectrum Pharmaceuticals Divests Rights to ZEVALIN® (ibritumomab tiuxetan) in...
HENDERSON, Nev. Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology,...
View ArticleClik here to view.
Cogstate iPad Cognitive Assessments Selected for Use in Phase IV...
NEW HAVEN, Conn. Cogstate Ltd (ASX:CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has...
View ArticleClik here to view.
PD-1/PD-L1 Combinations Drive the Development of New Immunotherapies
BOSTON, LONDON & TOKYO The immuno-oncology agents Keytruda and Opdivo have already transformed the cancer care landscape. Now specialists are pairing them with approved or experimental agents to...
View ArticleClik here to view.
New Survey Showed GI Health and Anti-Aging Benefits of Morinaga’s Probiotics...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), Japanese leading dairy product company, today unveiled the results of a nationwide survey jointly conducted with Tokyo Healthcare University in...
View ArticleClik here to view.
Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Benepali®...
View ArticleClik here to view.
ノボキュア、初発膠芽腫のEF-14臨床試験データの新しい分析を含め、腫瘍治療電場に関するプレゼンテーション18件がSNO 2015で行われると発表
ジャージー島セントへリア （ビジネスワイヤ） — 商業段階のオンコロジー企業ノボキュア（NASDAQ: NVCR）は本日、腫瘍治療電場（Tumor Treating...
View Article